Botox vs. patch: which stops drooling better in kids with cerebral palsy?
NCT ID NCT03616067
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compared two treatments for drooling in children with cerebral palsy: Botox injections into the salivary glands and scopolamine skin patches. Both groups also received rehabilitation therapy. The goal was to see which treatment reduced drooling more over 15 months. The trial was terminated early after enrolling only 23 children, so the results are limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Botulinum toxin A (Botox) injection and scopolamine (Scopoderm) patches
What this could lead to
If it works, this could point toward a more effective, longer-lasting treatment for drooling in children with cerebral palsy, improving quality of life.
What could go wrong
The trial was terminated early with only 23 participants, so results are limited. Both treatments have side effects, and the study may not provide clear answers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL PALSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HM
Marseille, France
-
APFESEAN Nantes
Nantes, France
-
CHU d'Angers
Angers, France
-
CHU- Estaing
Clermont-Ferrand, France
-
CHU-Bordeaux
Bordeaux, France
-
CHU-Grenoble
Grenoble, France
-
CHU-Nimes
Nîmes, France
-
Centre Médico-Chirurgical de Réadaptation des Massues
Lyon, 69322, France
-
Centre médico- infantile
Romagnat, France
-
Hôpital Femme Mère Enfant - HCL
Bron, France
-
Hôpitaux de Saint-Maurice
Saint-Maurice, France